ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
FDA Approves TicoVac (tick-borne encephalitis vaccine) to Prevent Tick-Borne Encephalitis (TBE)
August 20, 2021Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved TicoVac (tick-borne encephalitis (TBE) vaccine) for active immunization to prevent TBE in individuals 1 year of age and older. -
Pfizer’s tick-borne encephalitis vaccine gets US priority review
February 26, 2021The US Food and Drug Administration (FDA) has accepted for priority review Pfizer’s tick-borne encephalitis (TBE) vaccine to prevent TBE in children and adults aged one year or older.
Pharma Sources Insight January 2025
